Travis Doupe News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Travis doupe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Travis Doupe Today - Breaking & Trending Today
/PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing. ....
Willow or the Company ) (TSX: WLLW) (TSX: WLLW.WT) (OTCQX: CANSF) is pleased to announce that it has closed its previously announced upsized bought deal offering of 17,424,800 common shares (the Common Shares ) of the Company at a price of $1.65 per Common Share, which includes 2,272,800 Common Shares issued pursuant to the exercise in full of the over-allotment option, for aggregate gross proceeds of approximately $28.75 million (the Offering ). Participation in the Offering was comprised primarily of existing cornerstone shareholders and new institutional buyside funds. Net proceeds from the Offering are expected to be used to help access new markets for the Company s cannabinoid portfolio, expedite the commercialization of new cannabinoids, access additional manufacturing capacity, working capital and general corporate purposes. ....
Willow Biosciences Inc closed its previously upsized bought deal offering for aggregate gross proceeds of approximately $28.75M after full exercise of over-allotment option proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
19 febbraio 2021 17:28 Fonte: Adnkronos #chimica-e-farmacia VANCOUVER, BC, Feb. 19, 2021 /PRNewswire/ Willow Biosciences Inc. ( Willow or the Company ) (TSX: WLLW) (TSX: WLLW.WT) (OTCQX: CANSF) is pleased to announce that it has closed its previously announced upsized bought deal offering of 17,424,800 common shares (the Common Shares ) of the Company at a price of $1.65 per Common Share, which includes 2,272,800 Common Shares issued pursuant to the exercise in full of the over-allotment option, for aggregate gross proceeds of approximately $28.75 million (the Offering ). Participation in the Offering was comprised primarily of existing cornerstone shareholders and new institutional buyside funds. Net proceeds from the Offering are expected to be used to help access new markets for the Company s cannabinoid portfolio, expedite the commercialization of new cannabinoids, access additional manufacturing capacity, working capital and general corporate purpos ....
Willow Biosciences Announces Exercise of Over-Allotment Option and Completion of Previously Announced Bought Deal Offering prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.